Research Participants Wanted

New Opportunities

The impact of artificial sunlight on human sleep and circadian rhythms

Stanford University and the VA Palo Alto Health Care System are seeking participants for a research study investigating the use of light to improve sleep, mood, and performance.

  • Four overnight stays at the VA Sleep Lab
  • Four sets of at-home sleep monitoring (3 days each set)


Participants must be healthy, non-smokers, without sleep problems, between 18-35 years old. Compensation up to $650.00

Call (650) 493-5000 x 61971 or email Yvonne.quevedo@va.gov for more information.


Negative Symptoms of Schizophrenia

Stanford researchers are recruiting participants with schizophrenia or schizoaffective disorder who struggle with negative symptoms (such as inactivity, social withdrawal and emotional inexpressiveness). The purpose of this study is to find out what effects the study medication RO6889450 has on the negative symptoms of schizophrenia or schizoaffective disorder. If you would like further information or you’re interested in taking part please contact us at inspire-research@stanford.edu.


The Gratitude Study

Stanford researchers are recruiting participants with schizophrenia who have experienced weight gain due to taking antipsychotic medications. The purpose of this study is to find out whether an investigational study drug, Miricorilant, is safe and effective in reducing weight gain in participants taking antipsychotic medications. If you would like further information or you’re interested in taking part please contact us at inspire-research@stanford.edu.


Improving Cognition via Exercise in Schizophrenia (ICE)

Participants are invited to take part in a research study investigating the influence of exercise on cognitive functioning in individuals with schizophrenia. This study will examine the impact of exercise training on cognition, suicide risk, daily functioning, and biomarkers of cognitive change and suicidality in people with schizophrenia. Eligible participants will be randomized into aerobic exercise training or stretching and toning exercise training. Participants in both groups will take part in a 12-week, 3 times per week, 1-hour training program, in addition to their regular treatment. If you’re interested in taking part please contact us at inspire-research@stanford.edu.


Human Connectome study 

The research study is aimed at understanding behaviors and brain circuits that relate to anxiety and depression. The study will investigate the underlying brain circuits associated with these disorders, the relationship between the circuits and specific symptoms and behaviors, and how to use the brain circuit properties to predict symptom change. Participants must be 18-35 years of age and be currently experiencing depression and/or anxiety symptoms. Learn more and register for the study.


Early Detection of COVID-19 Infection Symptoms Using Wearable Devices - Empatica devices

Through this study, we are aiming to understand if the use of wearable devices, such as fitness trackers like the Empatica watch, can be used to early detect symptoms of infection disease, including the new COVID-19 respiratory infection. For this study, we will specifically target people at high risk of COVID-19 exposure. In light of the large invisible caseload and high transmission rates of COVID-19, as well as the lack of sufficient, widely available testing kits, alternative methods for early disease detection could provide a significant public health benefit during the outbreak. Our previous work has indicated that heart rate data measured using smartwatches can be useful for early detection of infectious disease. We have developed an algorithm, Change-of-Heart, that identified extremely outlying heart rate measurements and we showed that these outliers were often associated with infection. Participants will enroll for this 30-day-study, during which they must wear the Empatica watch and collect daily saliva samples using the provided at-home COVID-19 testing kits.

Please email covid19_empatica@stanford.edu to enroll.


Recruitment for healthy controls for PET Study

Interested in participating in research to advance understanding of the brain? Stanford researchers studying brain development in relation to behavior and cognition in adults with intellectual and developmental disabilities are looking for paid volunteers to participate in a research study at Stanford University that aims to develop new image-guided method for treating intellectual and developmental disabilities like fragile X syndrome (FXS). 

The study will involve receiving an investigational dye in your vein that will highlight specific areas of your brain and sampling a small quantity of blood from your artery on two separate days. Participants are paid up to $400 for completion of the study procedures. You will receive a picture of your brain after participating in two brain scans at least one week apart using an imaging system called positron emission tomography and magnetic resonance imaging (PET/MRI).

Contact chinresearchlab@stanford.edu.

For general questions about research participants' rights, contact 1-866-680-2906 


Stanford Home Sleep Study

The Stanford Home Sleep Study is seeking participants with or without sleep-time teeth grinding for a remote study that investigates the relationship between sleep and well-being. Receive a personalized sleep report, earn up to $80, and provide information that may help us develop interventions aimed at improving sleep and quality of life.

Learn more here. 

For questions, email homesleep@stanford.edu.


 Stanford Autism Spectrum Disorder and Intellectual Disability Research Registry

Does your child have autism? Researchers at Stanford University are developing a Research Registry to better understand the causes and treatment of Autism Spectrum Disorder (ASD) and Intellectual Disability (ID). The Research Registry will allow researchers to identify and recruit patients who might be eligible for participation in future research studies, and review and study the medical records of your child to help answer questions about ASD and/or ID and its treatment. In order to be part of the Research Registry, your child must have a diagnosis of Autism Spectrum Disorder and/or Intellectual Disability.  There is no cost to participate. For more information, call (650) 736-1235. Register here: http://med.stanford.edu/autism/registry.html


Stanford Hoarding Disorder Research Study

If you have difficulty with clutter, are feeling overwhelmed and needing help, and over 55, you may be eligible to receive peer-support group sessions paired with virtual reality (VR) sessions at no cost to you.

Physician Investigator: Carolyn Rodriguez, M.D, Ph.D., Stanford Medical Center

For more information contact: clutterhelp@stanford.edu ; 650-497-2577

Learn more here. Participant's right questions, contact 1-866-680-2906.


Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic

The COVID-19 Pandemic and mitigation efforts have drastically disrupted daily life and increased stress, causing worse sleep quality for many individuals across the world. The CoPsyN Sleep lab at Stanford University is conducting a study of a brief, non-drug therapy for acute sleep problems that have started or worsened during the COVID-19 Pandemic. Volunteers who are 18 years or older, experiencing sleep difficulties since the COVID-19 Pandemic, and currently living in the United States will receive extensive sleep evaluation and individualized telehealth treatment. There is no in-person contact in this study. If interested, please fill out an interest form (https://redcap.stanford.edu/surveys/?s=XRPF4NTRFA&fbclid=IwAR3jaC3z0OhlwC86_Hf9le8R7BgYbfImpeJzVCfJfI8XRmij_cCjeZeYnFc) or email Allie at amorehse@stanford.edu


Stanford PanLab Human Connectome Study

Participants are needed for this study. Feeling a lack of motivation? Noticing changes in your appetite and sleep? Experiencing low mood? Interested in learning more about how this relates to the circuitry of your brain? You must be 18-35 years old. Learn more about the study. If you have questions call 1-866-680-2906.


Janssen COVID-19 ENSEMBLE Vaccine study

The Janssen COVID-19 ENSEMBLE Vaccine study at Stanford (PI: Dr. Grant, ID) will be open for participant visits starting Monday, Oct. 12. This is a Phase 3, Randomized, Double-Blinded, Placebo Controlled trial. This study is available to essential workers as well as the public. Learn more about the study here.

Email the Stanford study team with any questions at vaccines_program@stanford.edu.


Treatment resistant depression study recruitment

Stanford researchers are recruiting participants with treatment resistant depression for a study to explore whether intravenous ketamine followed by the opioid buprenorphine produces more rapid and sustained anti-suicidal effects than ketamine followed by placebo. Researchers are recruiting 60 participants. Each participant will get one infusion of ketamine followed by four weeks of a medication or placebo. For information contact Jessica Hawkins at: jhawk@stanford.edu or call 650 723-8323.


COVID-19 long-term symptoms study

Stanford University researchers need your help to understand how COVID-19 symptoms evolve over time. Participants will be asked to fill out a brief online survey regarding their general health as well as symptoms that may have appeared after the COVID-19 illness began. The survey will repeat every three months for one year to assess change over time. Help spread the word and ask any adults you know who had or suspected they had COVID-19 to take this quick survey.


SPARK for Autism

SPARK for Autism seeks to speed up research and improve understanding of autism.  This includes learning what causes autism and how best to treat it. Stanford University and over 20 of the nation’s leading medical schools and autism research centers are part of this effort. Participating in SPARK is free and can be done entirely from home. Registration can be done entirely online at www.SPARKforAutism.org/stanford  and typically takes about 20 minutes. To participate in SPARK, please register, complete a few questionnaires online, and provide a saliva sample using a saliva collection kit that will be shipped directly to your home. Please contact sparkstudy@stanford.edu with any questions.


Volunteers needed for study on genomic analysis

Stanford University researchers are conducting a study focused on participants detailed genetic profile and dietary fiber supplementation to see the effects on the overall health and microbiome changes. Volunteers must be 18 years of age or older, and not pregnant. During the initial visit, researchers will collect samples for genomic analysis from volunteers. The participation period will take approximately seven weeks from start to finish. For more information reach out to Alessandra Celli.


Study on treatment resistant depression with suicidal ideation

A new study funded by the American Foundation for Suicide Prevention is recruiting people currently experiencing symptoms of depression and suicidal thoughts.  All eligible participants will receive one infusion of ketamine followed by four weeks of a medication or placebo. You may be eligible to participate in this six-week study if you are between 18-70 years of age and have not responded to previous depression treatment. Learn more about the study and complete an online screening form. Reach out to Jessica Hawkins with questions.


COVID-19 IRIS Study

The IRIS Study is currently seeking participants who have had symptoms of COVID-19 to learn more about infection recovery. Eligible subjects will be required to do an initial blood draw and participate in surveys, neuropsychological testing and a physical exam. There are two follow-up visits involving a chest x-ray and pulmonary function test. Participants will be compensated $80 per visit. For more information call (650) 498-7284 or email Mallika Rao.


Favipiravir study for asymptomatic and mild COVID-19

Favipiravir, an antiviral medicine, is currently used to treat influenza in some countries as well as mild and asymptomatic COVID-19. Researchers at Stanford Medicine are investigating if favipiravir may help patients get better faster, prevent them from getting worse and lower the chance of infection. The study is open to people within two days after they have tested positive for COVID-19. Learn more about the study. If you are interested in participating in the study, email treatcovid@stanford.edu.